Ketantin Uses, Dosage, Side Effects and more
Ketantin is a humanized anti-CD147 antibody being investigated as an add-on therapy in patients with COVID-19 pneumonia.
| Attribute | Details |
|---|---|
| Trade Name | Ketantin |
| Generic | Meplazumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Ketantin works
Ketantin is an anti-CD147 antibody, which is a recepor on host cells for viruses such as SARS-CoV2. Ketantin's inhibition of CD147 binding to the spike proteins of viruses is thought to inhibit their entry.
